Pyridostigmine Bromide
- Product NDC
- 68071-5032
- 11-digit product format
- 680715032
- Labeler code
- 68071
- Product ID
- 68071-5032_bbb38647-065a-381d-e053-2a95a90a12da
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PYRIDOSTIGMINE BROMIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA203184
- Marketing category
- ANDA
- Marketing start
- 2015-09-18
- Marketing end
- 0000-00-00
- Substance
- PYRIDOSTIGMINE BROMIDE
- Active strength
- 180 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-5032-3 | 68071503203 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-5032-3) | 2019-08-14 | 0000-00-00 | No | No | Current |